Treating hospitalized COVID-19 patients with anticoagulants–blood thinners that slow down clotting–may improve their chances of survival, researchers from the Mount Sinai COVID Informatics Center report. The study, published in the May 6 issue of the Journal of the American College of Cardiology, could provide new insight on how to treat and manage coronavirus patients once they are admitted to the hospital.
The study found that hospitalized COVID-19 patients treated with anticoagulants had improved outcomes both in and out of the intensive care unit setting. The research also showed that the difference in bleeding events among patients treated with and without anticoagulants was not significant. The Mount Sinai researchers say their work outlines an important therapeutic pathway for COVID-19 patients.
Logical since micro clots were reported. You mentioned that you had increased your daily aspirin . Was this before you got the virus and did that improve your recovery ? Some good news for those of us who are on blood thinners . I am on Apixaban since second PE 18 months ago.
Thank you for all the info you are sending on to us again. I missed it
I started the increase (doubled) when the symptoms manifested and went back to the normal 75mg after 14 days along with doubling of the nitrate pills which open up the arteries in the heart. I have no comparison on the recovery rate so that is an unknown. They were to me just logical "self administered" steps to take, after previously reading of the effects of Covid in the blood with the risk of micro clots, albeit not discussed, or approved by a doctor.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.